Long-term real-world effectiveness and safety of fremanezumab in 1140 patients with migraine and at least 6 months of treatment: third interim analysis of the pan-European PEARL study
在1140名偏头痛患者中,接受至少6个月治疗的fremanezumab的长期真实世界疗效和安全性:泛欧洲PEARL研究的第三次中期分析
期刊:Neurological Sciences
影响因子:2.4
doi:10.1007/s10072-025-08484-1
Ashina, Messoud; Mitsikostas, Dimos D; Amin, Faisal Mohammad; Kokturk, Pinar; Schankin, Christoph J; Sahin, Gurdal; Pozo-Rosich, Patricia; Dorman, Paul J; Nežádal, Tomáš; Poole, Anne Christine; Martins, Isabel Pavão; Sumelahti, Marja-Liisa; Ramirez Campos, Verena; Ahn, Andrew H; Akcicek, Hasan; Tassorelli, Cristina